![]() |
|
|
Vol. 294, Issue 1, 33-37, July 2000
Department of Pharmacology, Nagasaki University School of Medicine,
Nagasaki, Japan (M.O., M.K., K.T.); and Department of Applied Research,
Central Research Laboratories, Zeria Pharmaceutical Co., Ltd., Saitama,
Japan (M.O., S.U., T.K.)
The mechanism by which Z-338, a novel gastroprokinetic agent,
stimulates gastric motility was studied in relation to muscarinic receptors in the guinea pig. Z-338 (3-30 µM) enhanced electrically stimulated contractions and the release of acetylcholine (ACh) that was
tetrodotoxin sensitive and extracellular Ca2+ dependent, in
gastric strips. Membrane-binding assay revealed that
Z-338 possessed binding affinity for muscarinic M1
and M2, but not M3 receptors. In
Xenopus oocytes expressing M1 and
M2 muscarinic receptors, Z-338 did not produce any
response, but inhibited ACh-induced outward currents, thereby
indicating that Z-338 acts on the M1 and M2
muscarinic receptors as an antagonist. The M1 receptor
antagonist pirenzepine (0.5 µM) and M2 receptor antagonist AF-DX 116 (1 µM) also enhanced electrically stimulated release of ACh. These results indicate that Z-338 facilitates ACh
release from cholinergic nerve terminals by blocking muscarinic M1 and M2 autoreceptors, which regulate the
release of ACh.
This article has been cited by other articles:
![]() |
T. Takeuchi, K. Fujinami, H. Goto, A. Fujita, M. M. Taketo, T. Manabe, M. Matsui, and F. Hata Roles of M2 and M4 Muscarinic Receptors in Regulating Acetylcholine Release From Myenteric Neurons of Mouse Ileum J Neurophysiol, May 1, 2005; 93(5): 2841 - 2848. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Douglas, H. A. Baghdoyan, and R. Lydic M2 Muscarinic Autoreceptors Modulate Acetylcholine Release in Prefrontal Cortex of C57BL/6J Mouse J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 960 - 966. [Abstract] [Full Text] [PDF] |
||||